InsiderClue
Insiders · Profile

KINGSLEY ALFRED D

Director at Insight Molecular Diagnostics · See Remarks at Lineage Cell Therapeutics. Filing since 15 Nov 2012. CIK 0001229339

IMDX Insight Molecular Diagnostics Inc. Director · 6 trades LCTX Lineage Cell Therapeutics, Inc. See Remarks · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IMDX Insight Molecular Diagnostics Inc.
14 Jun 2023
Director
Bought
30,000
$6.45K
6.8%
IMDX Insight Molecular Diagnostics Inc.
22 Dec 2022
Director
Bought
25,000
$7.13K
6.0%
IMDX Insight Molecular Diagnostics Inc.
15 Aug 2022
Director
Bought
10,000
$9.70K
2.5%
IMDX Insight Molecular Diagnostics Inc.
23 Dec 2020
Director
Sold, plan not stated
900
$2.30K
0.3%
IMDX Insight Molecular Diagnostics Inc.
22 Dec 2020
Director
Sold, plan not stated
7,652
no price
2.3%
IMDX Insight Molecular Diagnostics Inc.
21 Dec 2020
Director
Sold, plan not stated
35,148
$13.08K
10.0%
LCTX Lineage Cell Therapeutics, Inc.
31 Jul 2017
See Remarks
Sold, plan not stated
150,000
$420.00K
2.5%
LCTX Lineage Cell Therapeutics, Inc.
20 Jan 2016
See Remarks
Sold, plan not stated
300,000
$705.00K
5.1%
LCTX Lineage Cell Therapeutics, Inc.
6 Nov 2015
See Remarks
Sold, plan not stated
100,000
$383.00K
1.7%
LCTX Lineage Cell Therapeutics, Inc.
16 May 2014
See Remarks
Sold, plan not stated
300,000
$735.00K
4.8%
LCTX Lineage Cell Therapeutics, Inc.
8 May 2014
See Remarks
Sold, plan not stated
300,000
$730.50K
4.6%
LCTX Lineage Cell Therapeutics, Inc.
4 Jun 2013
See Remarks
Sold, plan not stated
320,000
no price
4.6%
LCTX Lineage Cell Therapeutics, Inc.
28 Mar 2013
See Remarks
Sold, plan not stated
200,000
$762.00K
2.7%
LCTX Lineage Cell Therapeutics, Inc.
15 Nov 2012
See Remarks
Sold, plan not stated
344,828
$1.00M
4.6%
14 decisions on file.